New urine test could spot deadly pancreatic cancer sooner
NCT ID NCT04449406
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is working on a new way to detect pancreatic cancer early using a simple urine and blood test. Researchers are collecting samples from 3500 people, both with and without pancreatic disease, to see if a panel of biomarkers can accurately identify cancer. The goal is to create a reliable, non-invasive test that could lead to earlier diagnosis and better outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ADEPTS study, University College London
London, United Kingdom
-
EUROPAC study, University of Liverpool
Liverpool, United Kingdom
-
Imperial College London
London, United Kingdom
-
Royal London Hospital
London, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can High-Dose vitamin c boost Chemo's punch against pancreatic cancer?
- Four-Drug cocktail aims to shrink pancreatic tumors before surgery
- Exercise before and after pancreatic cancer surgery may speed recovery and chemotherapy start
- Could a simple blood test catch pancreatic cancer before It's too late?
- New drug combo aims to boost Chemotherapy's punch against pancreatic cancer
- New drug cocktail aims to shrink pancreatic tumors before surgery